UMB Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Sell |
1,935
-312
| -14% | -$17.2K | ﹤0.01% | 804 |
|
|
2025
Q1 | $159K | Buy |
2,247
+1,228
| +121% | +$86.8K | ﹤0.01% | 622 |
|
|
2024
Q4 | $67K | Buy |
1,019
+736
| +260% | +$48.4K | ﹤0.01% | 798 |
|
|
2024
Q3 | $19.9K | Buy |
283
+138
| +95% | +$9.7K | ﹤0.01% | 1237 |
|
|
2024
Q2 | $11.9K | Buy |
145
+107
| +282% | +$8.81K | ﹤0.01% | 1229 |
|
|
2024
Q1 | $3.32K | Hold |
38
| – | – | ﹤0.01% | 1425 |
|
|
2023
Q4 | $3.66K | Hold |
38
| – | – | ﹤0.01% | 1444 |
|
|
2023
Q3 | $3.36K | Hold |
38
| – | – | ﹤0.01% | 1476 |
|
|
2023
Q2 | $3.29K | Sell |
38
-30
| -44% | -$2.6K | ﹤0.01% | 1467 |
|
|
2023
Q1 | $6.61K | Buy |
+68
| New | +$6.61K | ﹤0.01% | 1374 |
|
|
2022
Q4 | – | Sell |
-108
| Closed | -$9K | – | 1717 |
|
|
2022
Q3 | $9K | Hold |
108
| – | – | ﹤0.01% | 1332 |
|
|
2022
Q2 | $9K | Hold |
108
| – | – | ﹤0.01% | 1414 |
|
|
2022
Q1 | $8K | Hold |
108
| – | – | ﹤0.01% | 1541 |
|
|
2021
Q4 | $10K | Buy |
+108
| New | +$10K | ﹤0.01% | 1446 |
|